HAITRAC-MED is a pharmaceutical company specializing in the manufacturing and marketing of branded generic pharmaceuticals in selected emerging markets, with a significant presence in Middle East and North Africa.

HAITRAC-MED specialized in the production and marketing of human pharmaceuticals, active pharmaceutical ingredients (API) and veterinary products. These core operations are supported by our consumer goods business lines, which includes empty glass ampoule and hygienic products manufacturing.

HAITRAC-MED organic growth strategy is to continue its growth in Egypt, to boost exports to selected emerging markets and to begin exporting to fully regulated markets in 2008.

HAITRAC-MED is also seeking to acquire pharmaceutical companies in Egypt and selected emerging markets including Russia, Ukraine, the CIS and certain countries in North Africa and the Middle East which have complementary product portfolios and which can be used to penetrate markets in which HAITRAC-MED presence is still low.